-
1
-
-
12344282783
-
Global burden of hypertension: Analysis of worldwide data
-
DOI 10.1016/S0140-6736(05)17741-1, PII S0140673605177411
-
Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-23 (Pubitemid 40138015)
-
(2005)
Lancet
, vol.365
, Issue.9455
, pp. 217-223
-
-
Kearney, P.M.1
Whelton, M.2
Reynolds, K.3
Muntner, P.4
Whelton, P.K.5
He, J.6
-
2
-
-
2342466734
-
Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030
-
DOI 10.2337/diacare.27.5.1047
-
Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53 (Pubitemid 38579764)
-
(2004)
Diabetes Care
, vol.27
, Issue.5
, pp. 1047-1053
-
-
Wild, S.1
Roglic, G.2
Green, A.3
Sicree, R.4
King, H.5
-
3
-
-
0032511580
-
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
-
UK Prospective Diabetes Study (UKPDS) Group
-
UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-13
-
(1998)
BMJ
, vol.317
, pp. 703-713
-
-
-
4
-
-
0036369914
-
The treatment of hypertension in adult patients with diabetes (Technical Review)
-
Arauz-Pacheco C, Parrott MA, Raskin P. The treatment of hypertension in adult patients with diabetes (Technical Review). Diabetes Care 2002; 25:134-47
-
(2002)
Diabetes Care
, vol.25
, pp. 134-147
-
-
Arauz-Pacheco, C.1
Parrott, M.A.2
Raskin, P.3
-
5
-
-
0036361987
-
Treatment of hypertension in adults with diabetes
-
American Diabetes Association
-
American Diabetes Association. Treatment of hypertension in adults with diabetes. Diabetes Care 2002;25:199-201
-
(2002)
Diabetes Care
, vol.25
, pp. 199-201
-
-
-
6
-
-
0034042724
-
Diabetes and hypertension physiopathology and therapeutics
-
Counteras F, Rivera M, Vasquez J, et al. Diabetes and hypertension physiopathology and therapeutics. J Hum Hypertens 2000;14:S26-S31 (Pubitemid 30406516)
-
(2000)
Journal of Human Hypertension
, vol.14
, Issue.SUPPL. 1
-
-
Contreras, F.1
Rivera, M.2
Vasquez, J.3
De La Parte, M.A.4
Velasco, M.5
-
7
-
-
0038306907
-
Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease
-
Reaven GM. Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J Clin Endocrinol Metabol 2003; 88:2399-403 (Pubitemid 36724403)
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, Issue.6
, pp. 2399-2403
-
-
Reaven, G.M.1
-
8
-
-
0036709996
-
Alcohol reduces insulin-hypertension relationship in a general population: The Hisayama study
-
DOI 10.1016/S0895-4356(02)00441-9, PII S0895435602004419
-
Arima H, Kiyohara Y, Kato I, et al. Alcohol reduces insulin-hypertension relationship in a general population: the Hisayama study. J Clin Epidemiol 2002;55:863-9 (Pubitemid 35246556)
-
(2002)
Journal of Clinical Epidemiology
, vol.55
, Issue.9
, pp. 863-869
-
-
Arima, H.1
Kiyohara, Y.2
Kato, I.3
Tanizaki, Y.4
Kubo, M.5
Iwamoto, H.6
Tanaka, K.7
Abe, I.8
Fujishima, M.9
-
9
-
-
57749186455
-
Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension
-
Lima NKC, Abbasi F, Lamendola C, et al. Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension. Am J Hypertens 2009;22:106-11
-
(2009)
Am J Hypertens
, vol.22
, pp. 106-111
-
-
Lima, N.K.C.1
Abbasi, F.2
Lamendola, C.3
-
10
-
-
77952304034
-
The Japanese Society of hypertension guidelines for the management of hypertension (JSH 2009)
-
The Japanese Society of Hypertension Committee
-
The Japanese Society of Hypertension Committee. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009;32:3-107
-
(2009)
Hypertens Res
, vol.32
, pp. 3-107
-
-
-
11
-
-
34547615709
-
2007 Guidelines for the management of arterial hypertension
-
DOI 10.1093/eurheartj/ehm236
-
Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension. Eur Heart J 2007;28:1462-536 (Pubitemid 47351115)
-
(2007)
European Heart Journal
, vol.28
, Issue.12
, pp. 1462-1536
-
-
Mancia, G.1
De Backer, G.2
Dominiczak, A.3
Cifkova, R.4
Fagard, R.5
Germano, G.6
Grassi, G.7
Heagerty, A.M.8
Kjeldsen, S.E.9
Laurent, S.10
Narkiewicz, K.11
Ruilope, L.12
Rynkiewicz, A.13
Schmieder, R.E.14
Struijker Boudier, H.A.J.15
Zanchetti, A.16
-
12
-
-
0038460302
-
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report
-
DOI 10.1001/jama.289.19.2560
-
Chobanian AV, Barkris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72 (Pubitemid 37430158)
-
(2003)
Journal of the American Medical Association
, vol.289
, Issue.19
, pp. 2560-2572
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
Cushman, W.C.4
Green, L.A.5
Izzo Jr., J.L.6
Jones, D.W.7
Materson, B.J.8
Oparil, S.9
Wright Jr., J.T.10
Roccella, E.J.11
-
13
-
-
78651338445
-
Standards of medical care in diabetes-2011
-
American Diabetes Association
-
American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care 2011;34(Suppl 1):S11-S61
-
(2011)
Diabetes Care
, vol.34
, Issue.SUPPL. 1
-
-
-
15
-
-
58249130250
-
Relation between cardiovascular complications and blood pressure/blood glucose control in diabetic patients with hypertension receiving long-term candesartan cilexetil therapy: Challenge-DM study
-
Kawamori R, Fujita T, Matsuoka H, et al. Relation between cardiovascular complications and blood pressure/blood glucose control in diabetic patients with hypertension receiving long-term candesartan cilexetil therapy: Challenge-DM study. Diabetes Res Clin Pract 2009;83:241-8
-
(2009)
Diabetes Res Clin Pract
, vol.83
, pp. 241-248
-
-
Kawamori, R.1
Fujita, T.2
Matsuoka, H.3
-
17
-
-
33748918856
-
Japanese Society of hypertension guidelines for the management of hypertension (JSH 2004)
-
Japanese Society of Hypertension
-
Japanese Society of Hypertension. Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004). Hypertens Res 2006;29(Suppl):S1-105
-
(2006)
Hypertens Res
, vol.29
, Issue.SUPPL.
-
-
-
18
-
-
38549181561
-
Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: Candesartan antihypertensive survival evaluation in Japan trial
-
DOI 10.1161/HYPERTENSIONAHA.107.098475, PII 0000426820080200000036
-
Ogihara T, Nakao K, Fukui T, et al. Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial. Hypertension 2008; 51:393-8 (Pubitemid 351159955)
-
(2008)
Hypertension
, vol.51
, Issue.2
, pp. 393-398
-
-
Ogihara, T.1
Nakao, K.2
Fukui, T.3
Fukiyama, K.4
Ueshima, K.5
Oba, K.6
Sato, T.7
Saruta, T.8
-
19
-
-
77953176878
-
Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial
-
Nakao K, Hirata M, Oba K, et al. Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial. Hypertens Res 2010;33:600-6
-
(2010)
Hypertens Res
, vol.33
, pp. 600-606
-
-
Nakao, K.1
Hirata, M.2
Oba, K.3
-
20
-
-
72549110348
-
Long-term effects of pioglitazone in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity
-
Kaku K, Daida H, Kashiwagi A, et al. Long-term effects of pioglitazone in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity. Curr Med Res Opin 2009;25:2925-32
-
(2009)
Curr Med Res Opin
, vol.25
, pp. 2925-2932
-
-
Kaku, K.1
Daida, H.2
Kashiwagi, A.3
-
21
-
-
26244453309
-
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial in macroVascular Events): A randomised controlled trial
-
DOI 10.1016/S0140-6736(05)67528-9, PII S0140673605675289
-
Dormandy JA, Charbonnel B, Eckland DJA, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomized controlled trial. Lancet 2005;366:1279-89 (Pubitemid 41416583)
-
(2005)
Lancet
, vol.366
, Issue.9493
, pp. 1279-1289
-
-
Dormandy, J.A.1
Charbonnel, B.2
Eckland, D.J.3
Erdmann, E.4
Massi-Benedetti, M.5
Moules, I.K.6
Skene, A.M.7
Tan, M.H.8
Lefebvre, P.J.9
Murray, G.D.10
Standl, E.11
Wilcox, R.G.12
Wilhelmsen, L.13
Betteridge, J.14
Birkeland, K.15
Golay, A.16
Heine, R.J.17
Koranyi, L.18
Laakso, M.19
Mokan, M.20
Norkus, A.21
Pirags, V.22
Podar, T.23
Scheen, A.24
Scherbaum, W.25
Schernthaner, G.26
Schmitz, O.27
Skrha, J.28
Smith, U.29
Taton, J.30
more..
-
22
-
-
0034627208
-
Randomized controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study
-
Mogensen CE, Neldam S, Tikkannen I, et al. Randomized controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ 2000;321:1440-4
-
(2000)
BMJ
, vol.321
, pp. 1440-1444
-
-
Mogensen, C.E.1
Neldam, S.2
Tikkannen, I.3
-
23
-
-
68249133888
-
Effects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease: Subanalysis of the CASE-J Study
-
Saruta T, Hayashi K, Ogihara T, et al. Effects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease: subanalysis of the CASE-J Study. Hypertens Res 2009;32:505-12
-
(2009)
Hypertens Res
, vol.32
, pp. 505-512
-
-
Saruta, T.1
Hayashi, K.2
Ogihara, T.3
-
24
-
-
77951621387
-
Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: A meta-analysis
-
Sarafidis PA, Stafylas PC, Georgianos PI, et al. Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis. Am J Kidney Dis 2010;55:835-47
-
(2010)
Am J Kidney Dis
, vol.55
, pp. 835-847
-
-
Sarafidis, P.A.1
Stafylas, P.C.2
Georgianos, P.I.3
-
25
-
-
0033669212
-
Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients
-
Nakamura T, Ushiyama C, Shimada N, et al. Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients. J Diabetes Complications 2000;14:250-4
-
(2000)
J Diabetes Complications
, vol.14
, pp. 250-254
-
-
Nakamura, T.1
Ushiyama, C.2
Shimada, N.3
|